Activation of diacylglycerol O-acyltransferase 1 gene results in increased tumor necrosis factor-α gene expression in 3T3-L1 adipocytes  by Hirata, Takashi et al.
FEBS Letters 580 (2006) 5117–5121Activation of diacylglycerol O-acyltransferase 1 gene results in
increased tumor necrosis factor-a gene expression in 3T3-L1 adipocytes
Takashi Hirataa, Hiroyuki Unokib, Hideaki Bujoc,*, Koichi Uenoa, Yasushi Saitod
a Department of Geriatric Pharmacology & Therapeutics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan
b Division of Applied Translational Research, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
c Department of Genome Research and Clinical Application, Graduate School of Medicine, Chiba University, 1-8-1 Inohana,
Chuo-ku, Chiba 260-8670, Japan
d Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Received 26 June 2006; revised 14 August 2006; accepted 16 August 2006
Available online 1 September 2006
Edited by Sandro SonninoAbstract The tumor necrosis factor-a (TNF-a) expression has
been reported to be largely dependent on the size of adipocytes.
We herein investigated the gene regulation of diacylglycerol O-
acyltransferase (DGAT) in order to clarify the mechanism of
TNF-a expression induced in large adipocytes. 3T3-L1 cells
were cultured in the presence of 5 mM or 25 mM glucose to gen-
erate adipocytes from which the triglyceride content diﬀers. The
expression of TNF-a, DGAT1, and DGAT2 were upregulated in
adipocytes cultured with 25 mM glucose. Furthermore, knock-
down of DGAT1 gene signiﬁcantly inhibited the TNF-a expres-
sion. Finally, the DGAT1 expression levels were closely related
to the TNF-a level in 3T3-L1 adipocytes.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Enlarged adipocytes isolated from either obese animals or
human exhibit modiﬁed metabolic properties and which do
not respond to exogenous stimuli as do adipocytes from lean
controls. Enlarged adipocytes develop a decreased sensitivity
to insulin [1–4] and produce increased quantities of secreted
cytokine such as tumor necrosis factor-a (TNF-a) [5,6] or lep-
tin [1,7]. An enlargement or accumulation of triglyceride (TG)
seems to be associated with cellular functions in adipocytes. It
is well known that the cytokine production from fat cells is
mainly dependent on the cell size, and the greater the accumu-
lation of TG, the larger the cell size that is induced. TG accu-Abbreviations: TNF-a, tumor necrosis factor-a; TG, triglyceride; D-
GAT, diacylglycerol O-acyltransferase; DMEM, Dulbecco’s modiﬁed
Eagle’s medium; Adipocytes with 5 mM glucose, adipocytes diﬀeren-
tiated with constant 5 mM glucose condition; Adipocytes with 25 mM
glucose, adipocytes diﬀerentiated with constant 25 mM glucose con-
ditions; siRNA(s), small interfering RNA(s)
*Corresponding author. Fax: +81 43 226 2095.
E-mail addresses: hi-unoki@faculty.chiba-u.jp (H. Unoki),
hbujo@faculty.chiba-u.jp (H. Bujo).
0014-5793/$32.00  2006 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2006.08.047mulation is largely induced by the increased TG synthesis. De
novo lipogenesis is known to be one possible mechanism
resulting in the accumulation of TG [8]. Among the many en-
zymes for the lipogenesis in adipocytes, diacylglycerol O-acyl-
transferase (DGAT) catalyzes the ﬁnal step in TG synthesis
[9,10]. Recent studies have suggested that an overexpression
of DGAT may play a role in insulin resistance [11,12]. How-
ever, the relationship between TG accumulation and the gene
expression in adipocytes has not yet been studied in relation to
DGAT expression and activation. In the light of these observa-
tions, the aim of the current study was to characterize the rela-
tionship between the expression of DGAT and TNF-a genes in
adipocytes.2. Materials and methods
2.1. Cell culture
The 3T3-L1 cells were obtained from the American Type Culture
Collection (Manassas, VA). The diﬀerentiation of 3T3-L1 preadipo-
cytes to mature adipocytes was performed using insulin, dexametha-
sone, and 3-isobutyl-1-methyl-xanthine essentially as described [13]
except that Dulbecco’s modiﬁed Eagle’s medium (DMEM; Sigma
Chemicals, St. Louis, MO) contained either 5 mM or 25 mM glucose.
Brieﬂy, 2 days after reaching the conﬂuence (day 0), diﬀerentiation was
induced by switching the medium into DMEM containing 10 lg/ml
insulin (Sigma Chemicals), 0.25 lM dexamethasone (Sigma Chemi-
cals), and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma Chemicals)
for 48 h. The cells were incubated with DMEM containing 5 lg/ml
insulin for further 48 h, then the medium was changed back with ori-
ginal DMEM containing 10% FBS and changed every 2 days. The cells
were used between days 14 and 21 after the induction of diﬀerentiation.2.2. Oil red O staining
The 3T3-L1 adipocytes diﬀerentiated either with constant 5 mM or
25 mM glucose condition (adipocytes with 5 mM or 25 mM glucose,
respectively) were ﬁxed with 10% formaldehyde (Wako Pure Chemical
Industries Ltd., Osaka, Japan) for 15 min at room temperature. After
ﬁxation, cells were stained with 0.3% oil red O solution for 10 min at
room temperature. The amount of TG was evaluated by measuring
the area stained with oil red-O using the Scion Image software (Scion
Corp., Fredrick, MD).2.3. Quantitative RT-PCR analysis
Total RNA was extracted from 3T3-L1 cells using an RNeasy kit
(Qiagen, Valencia, CA) and was reverse transcribed using the ExScript
RT-PCR Kit (Takara Bio Inc., Shiga, Japan). Quantitataive RT-PCR
ampliﬁcations were performed using TaqMan Universal PCR Master
Mix (PEApplied Biosystems, Foster City, CA) andAssays-on-Demandblished by Elsevier B.V. All rights reserved.
A5118 T. Hirata et al. / FEBS Letters 580 (2006) 5117–5121Gene expression Assay Mix (PE Applied Biosystems). All PCRs were
performed in an ABI PRISM 7000 sequence detection system (PE Ap-
plied Biosystems).
2.4. Glucose treatment
The 3T3-L1 adipocytes with 25 mM glucose were incubated with
DMEM without glucose supplemented with 10% FBS for 24 h. The
glucose-starved adipocytes were then treated with DMEM containing
10% FBS and various concentrations of glucose for 4–48 h. As an
osmotic control, adipocytes with 25 mM glucose were exposed to
mannitol instead of glucose. 5 mM 25 mM
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2.5. Suppression of DGAT1 and DGAT2 expression by small interfering
RNAs (siRNAs)
The 3T3-L1 adipocytes with 25 mM glucose were transfected with
siRNA duplexes by electroporation. In brief, 3T3-L1 adipocytes with
25 mM glucose were detached from culture dishes with 0.05% trypsin
and 0.02% EDTA (Sigma Chemicals), washed twice, and resuspended
in phosphate-buﬀered saline. Approximately 5 million cells were then
mixed with HP validated siRNA duplexes (Qiagen) either for DGAT1
or DGAT2, which were delivered to the cells by a pulse of electropor-
ation with a Bio-Rad gene pulser XL system (Bio-Rad Laboratories,
Hercules, CA) at the setting of 0.18 kV and 950 lF capacitance. After
electroporation, cells were reseeded onto multiple-well plates, and
incubated with DMEM containing 10% FBS and 25 mM glucose for
2 days. Glucose-starved adipocytes treated with siRNA were incubated
either with 0 mM or 25 mM glucose for 24 h, and the levels of TNF-a
and DGAT gene expression were analyzed by quantitative RT-PCR
analyses. Non-silencing ﬂuorescein-labeled siRNA duplexes (Qiagen)
were used as the control for unrelated siRNA transfections.D
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Fig. 1. Generation and characterization of adipocytes from which the2.6. Statistical analysis
The results are shown as means ± S.D. for each index, respectively.
Statistical signiﬁcance was determined by means of the Student’s t-test
or Dunnett’s multiple range test followed by ANOVA among several
groups; a value of P < 0.05 was considered as signiﬁcant.TG content diﬀers (A). 3T3-L1 cells were diﬀerentiated into adipocytes
either with 5 mM or 25 mM concentration of glucose and were stained
with oil-red O to identify the lipid droplet formation (magniﬁcation,
·20). (B) the quantiﬁcation of the amount of TG. Data represent the
means ± S.D. (n = 5). (C–D), the quantitation of DGAT1 (C) and
DGAT2 (D) mRNA in adipocytes with 5 mM glucose and adipocytes
with 25 mM glucose. The quantiﬁcation of each mRNA is expressed in
relation to the adipocytes with 5 mM glucose. 18S rRNA was used as
an internal control. Data represent the means ± S.D. (n = 4).
*P < 0.01.
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Fig. 2. The expression of the TNF-a gene is increased in adipocytes
with 25 mM glucose in comparison to that in adipocytes with 5 mM
glucose. The quantiﬁcation of each mRNA is expressed in relation to
the adipocytes with 5 mM glucose. Data represent the means ± S.D.3. Results
3.1. Increased TNF-a and DGAT gene expression in adipocytes
with 25 mM glucose
To generate and characterize of adipocytes of diﬀerent sizes,
we cultured 3T3-L1 cells with DMEM containing 5 mM or
25 mM glucose. A histological study using oil red O staining
revealed that adipocytes with 25 mM glucose have enlarged
adipocytes, and accumulated signiﬁcantly much TG in com-
parison to the adipocytes with 5 mM glucose (Fig. 1A and
B). We then examined mRNA expression levels for DGAT1
and DGAT2, which have been identiﬁed as the enzymes that
catalyze the ﬁnal step of TG synthesis. Both DGAT1 and
DGAT2 mRNA expression were found to be signiﬁcantly in-
creased in adipocytes with 25 mM glucose compared to adipo-
cytes with 5 mM glucose (DGAT1: 2.3-fold, DGAT2: 3.9-fold,
Fig. 1C and D). We next examined TNF-a mRNA expression,
which is a marker for functional changes in adipocytes [14–16].
The expression of TNF-a mRNA was 6.4-fold higher in adipo-
cytes with 25 mM glucose than in adipocytes with 5 mM glu-
cose (Fig. 2).(n = 4). *P < 0.01.3.2. Eﬀects of glucose on TNF-a and DGAT gene expression in
3T3-L1 adipocytes
To know the mechanism of the elevation of TNF-a and
DGAT mRNA in adipocytes with 25 mM glucose, we exam-
ined the eﬀects of glucose on TNF-a and DGAT mRNA
expression in 3T3-L1 adipocytes. Treatment with 25 mM glu-cose (designated as high glucose) for 24 h caused a 2.3-fold in-
crease of the TNF-a mRNA expression in 3T3-L1 adipocytes
with 25 mM glucose (Fig. 3A). Treatment with high glucose
for 24 h also induced both the DGAT1 and DGAT2 mRNA
expression, to a maximum of 3.0-fold and 2.7-fold, respectively
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Fig. 3. High glucose induces both the TNF-a and DGAT mRNA
expressions in 3T3-L1 adipocytes. After glucose-starvation for 24 h,
3T3-L1 adipocytes with 25 mM glucose were treated either with 25
mM glucose or mannitol for further 24 h ((A), (C), and (E)), or treated
with 25 mM glucose for the indicated time up to 48 h ((B), (D), and
(F)). d, 25 mM glucose; s, glucose-free (0 mM). Data represent the
means ± S.D. (n = 4). *P < 0.01 diﬀerences between the treatment
groups and controls.
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Fig. 4. High glucose induces TNF-a mRNA expression in 3T3-L1
adipocytes via the activation of the DGAT1 gene. DGAT1 (A) or
DGAT2 (B) mRNA was knocked down by siRNA duplexes in 3T3-L1
adipocytes with 25 mM glucose as described in Section 2. Fluorescein-
conjugated control siRNA was used as an unrelated control. The
expression of DGAT1 (A) and DGAT2 (B) gene was measured by
quantitative RT-PCR analyses. (C) The inactivation of the DGAT1
gene attenuates high glucose-induced TNF-a mRNA expression in
3T3-L1 adipocytes. The 3T3-L1 adipocytes were electroporated either
with DGAT1 or DGAT2 siRNA, and both the basal (0 mM glucose)
and high glucose (25 mM glucose)-treated levels of TNF-a mRNA
expression were determined. *P < 0.01, **P < 0.001.
T. Hirata et al. / FEBS Letters 580 (2006) 5117–5121 5119(Fig. 3C and E). As an osmotic control, 3T3-L1 adipocytes
with 25 mM glucose were exposed to 25 mM mannitol instead
of glucose, and no change in the expression of DGAT1,
DGAT2 and TNF-a mRNA was observed (Fig. 3A, C and
E). In the time course experiment, treatment with high glucose
for 24 h signiﬁcantly induced TNF-a mRNA, which then re-
mained at those levels until 48 h after glucose addition
(Fig. 3B). Similarly, treatment with high glucose increased
the levels of DGAT1 and DGAT2 mRNA in a time-dependent
manner to a maximum of 3.5-fold and 3.2-fold, respectively
(Fig. 3D and F). These results indicate that the time-course
induction is similar among DGAT1, DGAT2, and TNF-a
mRNA expression in 3T3-L1 adipocytes.
3.3. siRNA-mediated knock down of DGAT1 gene decreases
high glucose-induced TNF-a mRNA up-regulation
To elucidate the direct association between TNF-a and
DGAT gene expression, we tested whether the high glucose-in-
duced TNF-a mRNA up-regulation would be responsible for
that of DGAT. To knockdown the DGAT genes, we treated
3T3-L1 adipocytes with 25 mM glucose either with DGAT1
or DGAT2 speciﬁc siRNA duplexes. DGAT1 and DGAT2
siRNA reduced the expression of each isozyme to 15% and
5%, respectively (Fig. 4A and B). In addition, DGAT1 andDGAT2 siRNA also reduced the expression levels of DGAT2
and DGAT1 by 51% and 46%, respectively (Fig. 4A and B).
Unrelated siRNA did not aﬀect the high glucose-induced
TNF-a mRNA expression in 3T3-L1 adipocytes with 25 mM
glucose, in which a 2.3-fold increase of TNF-a mRNA expres-
sion was observed as shown in Fig. 3A. The inhibition of the
DGAT1 gene signiﬁcantly suppressed high glucose-induced
TNF-a gene expression to a closely similar level in the unre-
lated siRNA control. In contrast, DGAT2 inhibition did not
signiﬁcantly inﬂuence the high glucose-induced TNF-a mRNA
expression (Fig. 4C). These data strongly suggest that
DGAT1, but not DGAT2, contributes to the upregulation of
TNF-a mRNA expression.4. Discussion
In the current study, we generated and characterized the adi-
pocytes of diﬀerent sizes of 3T3-L1 cells. The cellular TG con-
tents and the expression of markers such as DGAT1 and
DGAT2 are increased in adipocytes with 25 mM glucose.
Moreover, adipocytes with 25 mM glucose display the induc-
tion of TNF-a mRNA. In particular, we focused on the
regulation of DGAT by glucose, especially in relation to the
TNF-a gene expression. Glucose increased DGAT1, DGAT2,
and TNF-a mRNA expression in 3T3-L1 adipocytes with
25 mM glucose. These results suggested that DGAT and
TNF-a mRNA expression in 3T3-L1 adipocytes is closely
related to each other. Finally, RNA interference experiments
showed the DGAT1 expression or activation is important for
5120 T. Hirata et al. / FEBS Letters 580 (2006) 5117–5121the TNF-a gene expression in adipocytes. We therefore pro-
pose that DGAT1 plays an important role in the regulation
of functions for the TNF-a production in adipocytes.
DGAT1 and DGAT2 are both believed to catalyze the ﬁnal
reaction in the TG synthesis pathways in adipocytes. Although
the ability to make TG is essential for normal physiology, ex-
cess accumulation of TG results in obesity and is associated
with insulin resistance. Mice lacking DGAT1 have an in-
creased energy expenditure and insulin sensitivity and thus
are protected against diet-induced obesity and glucose intoler-
ance [11]. The metabolic abnormality in the knockout mice
could possibly be due to a disturbed function of the adipo-
cytes, in addition to the degree of accumulated fat volume in
the mice. As a result, the augmentation of TG synthesis in
adipocytes by the transgenic overexpression of DGAT1 gene
causes obesity and/or decreases insulin sensitivity. Two-fold
greater DGAT activity levels in adipose tissue causes hypergly-
cemia, hyperinsulinemia, and glucose intolerance on a high-fat
diet in mice[17]. Although DGAT2 knockout mice demon-
strate decreased tissue triacylglycerol contents, similar to
DGAT1 knockout mice, they have disparate phenotypes, thus
suggesting that the two enzymes have functional diﬀerences. A
recent study indicated that DGAT1 utilizes a variety of acyl
acceptors as substrates in vitro [18]. These diﬀerent activities
between DGAT1 and DGAT2 may be relevant to the in vivo
functions of DGAT1. Our ﬁnding of a tight link between
DGAT1, and not DGAT2, and TNF-a expression may thus
be caused by the diﬀerent metabolic spectra between these en-
zymes. An over-accumulation of TG in adipocyte is well asso-
ciated with the development of insulin resistance, possibly in
part through the secretion of cytokines for the regulation of
insulin sensitivity. An animal model showed that the increase
in TG accumulation corresponded to an increase in the micro-
somal DGAT activity [19]. The expression of DGAT1 mRNA
changes the most in the liver and adipose tissue, whereas the
DGAT2 responses mainly induce changes in the muscle and
intestine. Thus, DGAT1 may therefore be responsible for the
elevated DGAT activity and the subsequent increase in de
novo lipogenesis, and lead to the cytokine secretion from adi-
pocytes.
The relationship between subcutaneous and visceral adipo-
cyte metabolism and development has been extensively studied
using primary cell cultures isolated from fat tissue [20]. We
have shown that adipocytes which accumulated in mesenteric
area, and not in the subcutaneous area, induce TNF-a gene
expression, thus leading to an increased concentration of
TNF-a in the serum using a cell transplantation method in
mice [14]. In fact, the decrease in visceral fat accumulation is
associated with a decrease in the serum concentration of
TNF-a and insulin resistance [21]. Winkler et al. recently re-
ported that TNF-a protein was expressed in the adipocytes
of depots in humans, and the cell volume of both adipocyte de-
pots was found to have a signiﬁcant positive correlation with
serum TNF-a level [22]. The cell volume of adipocyte is largely
dependent on the accumulation of TG. DGAT is a key enzyme
for the synthesis of TG in adipocytes. Therefore, in this study,
we analyzed the modulation of DGAT regarding the TNF-a
expression in adipocytes, independently of the cell size itself.
Our results indicate that DGAT1 activation is closely related
to the expression of TNF-a thus suggesting that DGAT1 plays
an important role in the regulation of cytokine expression
from adipocytes accumulated in the visceral area. The inhibi-tion of DGAT1, but not DGAT2, drastically inhibited the
TNF-a gene expression in adipocytes. Further attempts to elu-
cidate the relationship between the activation of DGAT1 gene
and the expression of TNF-a gene may help contribute to a
better understanding of the disturbance of the functions in
the adipocytes which accumulate in the visceral area, thus lead-
ing to insulin resistance in humans.
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